The Antiemetic Efficacy of Oral Ondansetron plus Intravenous Dexamethasone in Patients with Gynecologic Malignancies Receiving Carboplatin-Based Chemotherapy

By Markman M.   Kennedy A.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 43-46

Elsevier

Access to resources Recommend Favorite

Favorable Outcome of Ovarian Germ Cell Malignancies Treated with Cisplatin or Carboplatin-Based Chemotherapy: A Hellenic Cooperative Oncology Group Study

By Dimopoulos M.A.   Papadopoulou M.   Andreopoulou E.   Papadimitriou C.   Pavlidis N.   Aravantinos G.   Aspropotamitis A.   Anagnostopoulos A.   Fountzilas G.   Michalas S.   Pectacides D.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 70-74

Elsevier

Access to resources Recommend Favorite

Consolidation Radiotherapy after Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer

By Pickel H.   Lahousen M.   Petru E.   Stettner H.   Hackl A.   Kapp K.   Winter R.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 215-219

Elsevier

Access to resources Recommend Favorite

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

By Fujiwara K.   Sakuragi N.   Suzuki S.   Yoshida N.   Maehata K.   Nishiya M.   Koshida T.   Sawai H.   Aotani E.   Kohno I.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 637-643

Elsevier

Access to resources Recommend Favorite

Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers

By Markman Maurie   Markman Jon   Webster Kenneth   Zanotti Kristine   Kulp Barbara   Peterson Gertrude   Belinson Jerome  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 12, 2004-12 ,pp. : 741-744

Springer Publishing Company

Access to resources Recommend Favorite